EurekAlert! -
5 May 2021 06:00
(University of Southern Denmark Faculty of Health Sciences) In a Danish-Norwegian collaboration, researchers have shown a slightly increased rate of rare but serious types of cerebral blood clots as well as a generally increased rate of venous blood clots following vaccination with the AstraZeneca vaccine. The risk of such adverse events is considered very low for the individual vaccine recipient.
Share this Article